SuRo Capital Balance Sheet Health
Financial Health criteria checks 2/6
SuRo Capital has a total shareholder equity of $157.4M and total debt of $73.3M, which brings its debt-to-equity ratio to 46.6%. Its total assets and total liabilities are $233.8M and $76.3M respectively.
Key information
46.6%
Debt to equity ratio
US$73.31m
Debt
Interest coverage ratio | n/a |
Cash | US$32.74m |
Equity | US$157.44m |
Total liabilities | US$76.34m |
Total assets | US$233.78m |
Recent financial health updates
No updates
Recent updates
Pre-IPO AI And Exceptional Governance At Suro Capital
Oct 15We Think Some Shareholders May Hesitate To Increase SuRo Capital Corp.'s (NASDAQ:SSSS) CEO Compensation
May 30The SPAC Collapse Isn't Good News For SuRo Capital
Sep 08SuRo Capital GAAP EPS of -$3.08, revenue of $0.89M
Aug 03SuRo: M&A Outlook For 2022 Is Strong
Feb 04Investing Like A VC Fund With SuRo Capital Corp.
Aug 31SuRo Capital declares $2.50 dividend
May 05SuRo Capital estimates year-end 2020 NAV up to $15.50 per share
Jan 11Best Idea For 2021: SuRo Capital
Jan 04Suro Capital: Venture Capital Investing For The Little Guy
Dec 27SuRo Capital declares $0.22 dividend
Dec 16SuRo stock rises 5.4% after clarifying Palantir stake; sees mid-December dividend
Nov 27SuRo Capital Corp. 2020 Q3 - Results - Earnings Call Presentation
Nov 08SuRo Capital declares $0.25 dividend
Oct 28Financial Position Analysis
Short Term Liabilities: SSSS's short term assets ($33.0M) exceed its short term liabilities ($2.6M).
Long Term Liabilities: SSSS's short term assets ($33.0M) do not cover its long term liabilities ($73.8M).
Debt to Equity History and Analysis
Debt Level: SSSS's net debt to equity ratio (25.8%) is considered satisfactory.
Reducing Debt: SSSS's debt to equity ratio has increased from 18.1% to 46.6% over the past 5 years.
Debt Coverage: SSSS's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if SSSS's interest payments on its debt are well covered by EBIT.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/24 06:19 |
End of Day Share Price | 2024/12/24 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
SuRo Capital Corp. is covered by 6 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Alexander Paris | Barrington Research Associates, Inc. |
Marvin Fong | BTIG |
Jon Hickman | Ladenburg Thalmann & Company |